AGA GUIDELINES Bundle (free trial)

Irritable Bowel Syndrome

AGA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/784446

Contents of this Issue

Navigation

Page 3 of 3

106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 For additional copies, order at GuidelineCentral.com Copyright © 2016 All rights reserved AGAIBS16083 Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Abbreviations AGA, American Gastroenterological Association; IBS, irritable bowel syndrome; IBS-C, irritable bowel syndrome with constipation-predominant symptoms; IBS-D, irritable bowel syndrome with diarrhea-predominant symptoms; IBS-M, irritable bowel syndrome with mixed pattern; PEG, polyethylene glycol; SSRIs, selective serotonin reuptake inhibitors; TCAs, tricyclic antidepressants Source Weinberg DS, Smalley W, Heidelbaugh JJ, Sultan S. American Gastroenterological Association Institute Guideline on the Pharmacological Management of Irritable Bowel Syndrome. Gastroenterolog y 2014;147:1146–1148. GRADE Strength of Recommendations and Implications Grade Implications of strong and conditional (weak) guideline recommendations Strong • Patients: Most people in this situation would want the recommended course of action, and only a small proportion would not. Formal decision aids are not likely to be needed to help patients make decisions consistent with their values and preferences. • Clinicians: Most patients should receive the recommended course of action. Adherence to this recommendation according to guidelines could be used as a quality criterion or a performance indicator. • Policy makers: The recommendation can be adapted as a policy in most situations. Conditional (weak) • Patients: Most people in this situation would want the recommended course of action, and only a small proportion would not. Formal decision aids are not likely to be needed to help patients make decisions consistent with their values and preferences. • Clinicians: Most patients should receive the recommended course of action. Adherence to this recommendation according to guidelines could be used as a quality criterion or a performance indicator. • Policy makers: The recommendation can be adapted as a policy in most situations. Reprinted with permission from Sultan et al. Clin Gastroenterol Hepatol. 201311:329–332. Visit gastro.org/guidelinesapp to learn about the AGA Clinical Guidelines App. Available for download on the iTunes and Google Play Store.

Articles in this issue

Links on this page

Archives of this issue

view archives of AGA GUIDELINES Bundle (free trial) - Irritable Bowel Syndrome